FindTrial
Sign In

Effectiveness of Exoskeleton to improve function of affected hand in patients with stroke

Effectiveness of Gravity supported, Computer enhanced Exoskeleton to Promote Recovery of Upper Limb Function for Patients after Stroke A randomized control study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084305
Enrollment
52
Registered
2025-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I68- Cerebrovascular disorders in diseases classified elsewhere Health Condition 2: I68- Cerebrovascular disorders in diseases classified elsewhere

Interventions

Intervention1: Goal directed Exoskeleton based rehabilitation with computer enhanced real time feedback: The intervention group undergoes training of the affected upper limb with Armeospring upper ex

Sponsors

Fluid Research Grant, CMC Vellore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Patients with history of cerebrovascular accident -Admitted for rehabilitation for a minimum duration of 6 weeks.-Clinical and radiological diagnosis of Ischemic / Haemorrhagic strok,1 month to 2 years after stroke,First episode of stroke,Severe to mild unilateral upper limb paresis of the dominant or non dominant UE,Patients with mild or no cognitive deficit ,Able to sit for 1 hour

Exclusion criteria

Exclusion criteria: -Significant impairment in the vision,Unstable medical conditions,Severe neuropathic pain,Severe spasticity ,Contracture or in the affected UL, coexisting neurological illnesses, Prior botulinum toxin injections , previously participated in robotic therapy in the upper extremities, Pregnant women

Design outcomes

Primary

MeasureTime frame
-The Upper extremity subscale of the Motricity Index (MI arm) -Motor Domain Scale of Fugl Meyer Upper Extremity scale -Action Research Arm test (ARAT) -Armeospring measures- AROM, AMove Timepoint: Intervention-Baseline,2weeks,1 month, 3month Control- Baseline,2weeks,1 month, 6 weeks, 3month—

Secondary

MeasureTime frame
--Modified Barthel Index -Modified Ashworth Scale -Patient Global Impression Scale of Change Timepoint: -Modified Barthel Index-baseline, 2 weeks, 1 month, 3 month. For control- 6 weeks in addition -Modified Ashworth Scale-baseline, 2 weeks, 1 month, 3 month. For control 6 weeks in addition -Patient Global Impression Scale of Change-at 2 weeks—

Countries

India

Contacts

Public ContactDr Vijay Sivaraj

Christian Medical College, Vellore

rajithomas@cmcvellore.ac.in0416-2282158

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026